Investment
Features
FeesSafety
Academy
More
Pluang+

Compare UBC Medical Indonesia Tbk. (LABS) vs Singaraja Putra Tbk. (SINI) Price & Performance

UBC Medical Indonesia Tbk.Trade
Singaraja Putra Tbk.Trade

Price performance (Past 24H)

Key statistics

UBC Medical Indonesia Tbk. vs Singaraja Putra Tbk. — how do they compare? UBC Medical Indonesia Tbk. trades at Rp165 (market cap 635.95B, 843K 24h volume), while Singaraja Putra Tbk. trades at Rp7,000 (market cap 8.51T, 514.5K 24h volume). The key difference: Singaraja Putra Tbk. is far larger — about 13.4× UBC Medical Indonesia Tbk.'s market cap, and UBC Medical Indonesia Tbk. is more actively traded (843K versus 514.5K). Which is the better fit depends on your goals.

LABSSINI
Market Cap
635.95B8.51T
Volume
843K514.5K
Lot
8.43K5.15K
Turnover
137.6M3.57B
Average Price
163.226,930.23
Value
137.6M3.57B
Indicative Equilibrium Price
1657,000
Indicative Equilibrium Volume
246469

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

LABS
View details
SINI
View details

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS

About Singaraja Putra Tbk.

PT Singaraja Putra Tbk (the Company) was established based on Notarial Deed No. 52 dated November 23, 2005 of Notary Sri Herawati Anwar Effendi, S.H. The Company commenced commercialoperations in 2006.

Read more on SINI